These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2364998)

  • 1. Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release.
    Zetterström T; Fillenz M
    Eur J Pharmacol; 1990 May; 180(1):137-43. PubMed ID: 2364998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of locally infused 2-chloroadenosine, an A1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum.
    Ballarin M; Reiriz J; Ambrosio S; Mahy N
    Neurosci Lett; 1995 Feb; 185(1):29-32. PubMed ID: 7731548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum.
    Golembiowska K; Zylewska A
    Brain Res; 1998 Sep; 806(2):202-9. PubMed ID: 9739141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in rat striatal dopamine synthesis and metabolism in vivo by metabolically stable adenosine receptor agonists.
    Myers S; Pugsley TA
    Brain Res; 1986 Jun; 375(1):193-7. PubMed ID: 3013369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum.
    Okada M; Mizuno K; Kaneko S
    Neurosci Lett; 1996 Jul; 212(1):53-6. PubMed ID: 8823761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.
    Gołembiowska K; Dziubina A; Kowalska M; Kamińska K
    Pharmacol Rep; 2008; 60(3):319-30. PubMed ID: 18622056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium ion augmentation of inhibitory effects of adenosine on dopamine release in the rat striatum.
    Okada M; Mizuno K; Okuyama M; Kaneko S
    Psychiatry Clin Neurosci; 1996 Jun; 50(3):147-56. PubMed ID: 9201762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF; Lu GH; Pugsley TA
    Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adenosine kinase, adenosine deaminase and transport inhibitors on striatal dopamine and stereotypy after methamphetamine administration.
    Gołembiowska K; Zylewska A
    Neuropharmacology; 2000 Aug; 39(11):2124-32. PubMed ID: 10963755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.
    De Klippel N; Sarre S; Ebinger G; Michotte Y
    Brain Res; 1993 Dec; 630(1-2):57-64. PubMed ID: 8118706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S; Johansson B; Fredholm BB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation.
    Wood PL; Kim HS; Boyar WC; Hutchison A
    Neuropharmacology; 1989 Jan; 28(1):21-5. PubMed ID: 2538767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interactions between magnesium ion and adenosine on monoaminergic system in the central nervous system.
    Okada M; Kaneko S
    Magnes Res; 1998 Dec; 11(4):289-305. PubMed ID: 9884987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
    Andrés ME; Gysling K; Bustos G
    Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis.
    Okada M; Kiryu K; Kawata Y; Mizuno K; Wada K; Tasaki H; Kaneko S
    Eur J Pharmacol; 1997 Feb; 321(2):181-8. PubMed ID: 9063686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of A1 and A2 adenosine receptors in the rat spinal cord.
    Choca JI; Proudfit HK; Green RD
    J Pharmacol Exp Ther; 1987 Sep; 242(3):905-10. PubMed ID: 3656118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against acute MPTP-induced dopamine depletion in mice by adenosine A1 agonist.
    Lau YS; Mouradian MM
    J Neurochem; 1993 Feb; 60(2):768-71. PubMed ID: 8419552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.